FDA Inspection
Hainan Poly Pharm. Co., Ltd.FDA Inspection 1102926 - Hainan Poly Pharm. Co., Ltd. - September 19, 2019
Record Details
This FDA Inspection record concerns Hainan Poly Pharm. Co., Ltd., with an inspection on September 19, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Hainan Poly Pharm. Co., Ltd.
- Inspection Date
- September 19, 2019
- Product Type
- Drugs
View Company Profile
ID · c28a8d88-84bc-4a47-ba85-212a400618c4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1102926
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Hainan Poly Pharm. Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 30, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 29, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hainan Poly Pharm. Co., Ltd.
- FDA Inspection 1210935 - 2023-06-30
- FDA Inspection 956953 - 2016-01-29
- FDA Inspection 877469 - 2014-01-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.